Tag:
Department of Justice
Latest Headlines
Latest Headlines
Medtronic: DOJ closes inquiry into Infuse sales practices
Medtronic can cross off its list one more lingering legal problem relating to the company's controversial Infuse bone graft material.
Indian government defends country's generics industry
A major government official in India is blasting what he says are attempts to target the country's generic drug industry as substandard or inferior.
U.S. wants more than $1B from J&J in Risperdal settlement
Johnson & Johnson ( $JNJ ) may have thought it had its Risperdal marketing problems almost wrapped up. But it was wrong. As The Wall Street Journal reports, Justice Department higher-ups have...
Feds probe Cephalon on Provigil, Nuvigil promos
The Justice Department isn't just interested in Cephalon's Treanda operations. It's also looking at the drugmaker's wakefulness meds Nuvigil and Provigil. Cephalon ( $CEPH ) said the feds issued a
J&J's Scios to plead guilty, pay $85M in Natrecor case
Johnson & Johnson's ( $JNJ ) legion of legal problems is one less strong. The company agreed to pay $85 million and plead guilty to a misdemeanor charge in a Justice Department probe of its
J&J, feds reach deal on one Risperdal charge
Johnson & Johnson ( $JNJ ) has come to terms with the Justice Department on one Risperdal marketing charge. It's a single misdemeanor, stemming from a long-running investigation of allegations that
DoJ subpoenas AZ, Medco about four meds
AstraZeneca and Medco Health Solutions are under the Department of Justice's microscope. Prosecutors have subpoenaed the drugmaker and pharmacy benefits manager about their relationship, asking
Serono to pay $44M in U.S. kickbacks case
Another whistleblower lawsuit has ended with a settlement. Merck Serono has agreed to pay $44.3 million to resolve claims that it paid doctors to prescribe its multiple sclerosis drug Rebif, the
Elan settles DoJ marketing probe for $203M
Elan has come to terms with the U.S. Justice Department. In the latest whistleblower settlement, the Irish drugmaker agreed to pay $203 million and plead guilty to a misdemeanor violation of the
DoJ adds weight to Abbott whistleblower suit
The Justice Department is joining a whistleblower suit against Abbott Laboratories that alleges the drugmaker promoted its seizure drug Depakote for off-label uses. Former employees claim Abbott
